Isis Pharmaceuticals, Inc. (JOBS) Says Cholesterol Drug Works; But Safety Weighs

February 11, 2010 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

Reuters -- Isis Pharmaceuticals Inc (ISIS.O) said on Wednesday its cholesterol-lowering drug mipomersen was effective in a late-stage clinical trial, but safety concerns pushed the company's shares down as much as 20 percent.

Twitter
LinkedIn
Facebook
Email
Print

Clinical research Phase III